Shenyang Xingqi Pharmaceutical Hits Day High with 3.29% Surge

Shenyang Xingqi Pharmaceutical Co., Ltd. has shown significant activity today, achieving a notable gain of 3.29% on March 11, 2026. The stock reached an intraday high of CNY 73.50, reflecting its strong performance in the pharmaceuticals and biotechnology sector. Over the past year, Shenyang Xingqi has outperformed the China Shanghai Composite, generating a return of 43.4% compared to the index's 22.3%. The company's robust financial metrics include a remarkable net profit growth of 117.45% and an operating cash flow of CNY 635.84 million, indicating strong operational efficiency. With a return on equity (ROE) of 28.64% and a price-to-book ratio of 9.15, the company maintains an attractive valuation. Additionally, its dividend yield stands at 1.9%, further enhancing its appeal. Shenyang Xingqi's performance over various time frames, including a 121.49% increase over five years, underscores its position as a reliable performer in the market.